VCEL
Vericel Corporation$40.08+0.47 (+1.19%)Prev Close$39.60·MCap$2.03B·P/E96.16·Vol326.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
29
$6.86M
◆
Net Activity
Net Seller
$6.86M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Vericel Corporation (VCEL) has been exclusively selling, with 0 insider purchases totaling $0.00 and 29 insider sales totaling $6.86M. The most recent insider transaction was by MCLAUGHLIN KEVIN F (director), who sold $311.7K worth of shares on Aug 14, 2026. Vericel Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.03B.
VCEL Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 7,000 | $44.53 | $311.7K | 18,300-28% |
| Aug 5, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $46.84 | $468.4K | 16,394-38% |
| Jul 31, 2026 | SIEGAL JONATHAN | officer: Principal Accounting Officer | Sell | 500 | $48.90 | $24.4K | 1,078-32% |
| Jun 30, 2026 | SIEGAL JONATHAN | officer: Principal Accounting Officer | Sell | 2,500 | $44.90 | $112.3K | 886-74% |
| Jun 30, 2026 | Flynn Sean C. | officer: Chief Legal Officer | Sell | 15,000 | $45.64 | $684.6K | 1,647-90% |
| Jun 30, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 5,000 | $45.00 | $225.0K | 75,753 |
| Jun 30, 2026 | Mara Joseph Anthony Jr | officer: Chief Financial Officer | Sell | 5,000 | $44.75 | $223.8K | 16,009 |
| Jun 22, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $40.24 | $402.4K | 16,248-38% |
| Jun 22, 2026 | Flynn Sean C. | officer: Chief Legal Officer | Sell | 15,000 | $40.21 | $603.1K | 1,647-90% |
| Jun 4, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 4,375 | $35.00 | $153.1K | 75,753 |
| May 15, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 3,500 | $32.82 | $114.9K | 18,300 |
| May 13, 2026 | Wotton Paul K | director | Sell | 10,000 | $32.74 | $327.4K | 26,302-28% |
| May 8, 2026 | SIEGAL JONATHAN | officer: Principal Accounting Officer | Sell | 4,855 | $38.73 | $188.0K | 2,540-66% |
| May 8, 2026 | Mara Joseph Anthony Jr | officer: Chief Financial Officer | Sell | 5,000 | $40.50 | $202.5K | 21,009 |
| Apr 6, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 3,472 | $35.00 | $121.5K | 75,556 |
| Mar 25, 2026 | Hagen Heidi | director | Sell | 15,000 | $32.41 | $486.1K | 31,850-32% |
| Feb 18, 2026 | Colangelo Dominick | President and CEO | Sell | 5,657 | $37.41 | $211.6K | 0 |
| Feb 18, 2026 | Flynn Sean C. | Chief Legal Officer | Sell | 2,520 | $37.06 | $93.4K | 0 |
| Feb 18, 2026 | Halpin Michael | Chief Operating Officer | Sell | 4,298 | $37.07 | $159.3K | 0 |
| Feb 18, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 982 | $37.41 | $36.7K | 0 |
| Feb 18, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 2,314 | $37.03 | $85.7K | 0 |
| Feb 18, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,305 | $36.90 | $48.2K | 0 |
| Feb 13, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 7,000 | $34.66 | $242.6K | 15,100-32% |
| Jan 9, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $40.48 | $404.8K | 16,080-38% |
| Dec 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 1,652 | $39.14 | $64.7K | 66,562 |
| Dec 4, 2025 | Wotton Paul K | Sell | 5,000 | $37.90 | $189.5K | 28,102 | |
| Nov 13, 2025 | Halpin Michael | Chief Operating Officer | Sell | 2,642 | $40.41 | $106.8K | 15,932 |
| Nov 12, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $38.59 | $270.1K | 15,100-32% | |
| Nov 10, 2025 | Halpin Michael | Chief Operating Officer | Sell | 7,358 | $40.47 | $297.8K | 15,932-32% |
| Sep 3, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $35.77 | $357.7K | 66,363 |
| Aug 8, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $35.92 | $251.4K | 15,100-32% | |
| Jun 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $40.09 | $400.9K | 66,237 |
| May 16, 2025 | Colangelo Dominick | President and CEO | Sell | 28,125 | $41.89 | $1.18M | 260,354 |
| May 9, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $39.98 | $279.9K | 15,100-32% | |
| Apr 11, 2025 | Colangelo Dominick | President and CEO | Sell | 49,700 | $41.50 | $2.06M | 260,354 |
| Mar 14, 2025 | Colangelo Dominick | President and CEO | Sell | 53,183 | $46.04 | $2.45M | 259,997 |
| Mar 5, 2025 | Hagen Heidi | Sell | 9,000 | $49.53 | $445.8K | 28,650 | |
| Mar 5, 2025 | Halpin Michael | Chief Operating Officer | Sell | 10,000 | $49.52 | $495.2K | 15,539-39% |
| Mar 5, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $49.53 | $495.3K | 66,101 |
| Mar 5, 2025 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 9,000 | $49.53 | $445.8K | 13,967-39% |
| Feb 26, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 1,669 | $52.07 | $86.9K | 756-69% |
| Feb 26, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,137 | $52.07 | $59.2K | 1,206-49% |
| Feb 24, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 3,835 | $57.32 | $219.8K | 756-84% |
| Feb 20, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,710 | $56.72 | $97.0K | 1,206-59% |
| Feb 14, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.46 | $388.3K | 11,900-37% | |
| Feb 7, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,092 | $61.99 | $67.7K | 1,206-48% |
| Feb 7, 2025 | ZERBE ROBERT L MD | Sell | 2,500 | $62.50 | $156.3K | 26,595 | |
| Jan 30, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3,908 | $61.99 | $242.3K | 1,206-76% |
| Dec 5, 2024 | Wotton Paul K | Sell | 2,600 | $58.72 | $152.7K | 27,402 | |
| Dec 3, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $58.72 | $587.2K | 58,371 |
Showing 1–50 of 115
1 / 3
VCEL Insider Buying Activity
The following table shows recent insider purchases of Vericel Corporation (VCEL) stock reported via SEC Form 4 filings.
No insider buying activity found for VCEL in the last 12 months.
VCEL Insider Selling Activity
The following table shows recent insider sales of Vericel Corporation (VCEL) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 7,000 | $44.53 | $311.7K | 18,300-28% |
| Aug 5, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $46.84 | $468.4K | 16,394-38% |
| Jul 31, 2026 | SIEGAL JONATHAN | officer: Principal Accounting Officer | Sell | 500 | $48.90 | $24.4K | 1,078-32% |
| Jun 30, 2026 | SIEGAL JONATHAN | officer: Principal Accounting Officer | Sell | 2,500 | $44.90 | $112.3K | 886-74% |
| Jun 30, 2026 | Flynn Sean C. | officer: Chief Legal Officer | Sell | 15,000 | $45.64 | $684.6K | 1,647-90% |
| Jun 30, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 5,000 | $45.00 | $225.0K | 75,753 |
| Jun 30, 2026 | Mara Joseph Anthony Jr | officer: Chief Financial Officer | Sell | 5,000 | $44.75 | $223.8K | 16,009 |
| Jun 22, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $40.24 | $402.4K | 16,248-38% |
| Jun 22, 2026 | Flynn Sean C. | officer: Chief Legal Officer | Sell | 15,000 | $40.21 | $603.1K | 1,647-90% |
| Jun 4, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 4,375 | $35.00 | $153.1K | 75,753 |
| May 15, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 3,500 | $32.82 | $114.9K | 18,300 |
| May 13, 2026 | Wotton Paul K | director | Sell | 10,000 | $32.74 | $327.4K | 26,302-28% |
| May 8, 2026 | SIEGAL JONATHAN | officer: Principal Accounting Officer | Sell | 4,855 | $38.73 | $188.0K | 2,540-66% |
| May 8, 2026 | Mara Joseph Anthony Jr | officer: Chief Financial Officer | Sell | 5,000 | $40.50 | $202.5K | 21,009 |
| Apr 6, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 3,472 | $35.00 | $121.5K | 75,556 |
| Mar 25, 2026 | Hagen Heidi | director | Sell | 15,000 | $32.41 | $486.1K | 31,850-32% |
| Feb 18, 2026 | Colangelo Dominick | President and CEO | Sell | 5,657 | $37.41 | $211.6K | 0 |
| Feb 18, 2026 | Flynn Sean C. | Chief Legal Officer | Sell | 2,520 | $37.06 | $93.4K | 0 |
| Feb 18, 2026 | Halpin Michael | Chief Operating Officer | Sell | 4,298 | $37.07 | $159.3K | 0 |
| Feb 18, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 982 | $37.41 | $36.7K | 0 |
| Feb 18, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 2,314 | $37.03 | $85.7K | 0 |
| Feb 18, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,305 | $36.90 | $48.2K | 0 |
| Feb 13, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 7,000 | $34.66 | $242.6K | 15,100-32% |
| Jan 9, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $40.48 | $404.8K | 16,080-38% |
| Dec 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 1,652 | $39.14 | $64.7K | 66,562 |
| Dec 4, 2025 | Wotton Paul K | Sell | 5,000 | $37.90 | $189.5K | 28,102 | |
| Nov 13, 2025 | Halpin Michael | Chief Operating Officer | Sell | 2,642 | $40.41 | $106.8K | 15,932 |
| Nov 12, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $38.59 | $270.1K | 15,100-32% | |
| Nov 10, 2025 | Halpin Michael | Chief Operating Officer | Sell | 7,358 | $40.47 | $297.8K | 15,932-32% |
| Sep 3, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $35.77 | $357.7K | 66,363 |
| Aug 8, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $35.92 | $251.4K | 15,100-32% | |
| Jun 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $40.09 | $400.9K | 66,237 |
| May 16, 2025 | Colangelo Dominick | President and CEO | Sell | 28,125 | $41.89 | $1.18M | 260,354 |
| May 9, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $39.98 | $279.9K | 15,100-32% | |
| Apr 11, 2025 | Colangelo Dominick | President and CEO | Sell | 49,700 | $41.50 | $2.06M | 260,354 |
| Mar 14, 2025 | Colangelo Dominick | President and CEO | Sell | 53,183 | $46.04 | $2.45M | 259,997 |
| Mar 5, 2025 | Hagen Heidi | Sell | 9,000 | $49.53 | $445.8K | 28,650 | |
| Mar 5, 2025 | Halpin Michael | Chief Operating Officer | Sell | 10,000 | $49.52 | $495.2K | 15,539-39% |
| Mar 5, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $49.53 | $495.3K | 66,101 |
| Mar 5, 2025 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 9,000 | $49.53 | $445.8K | 13,967-39% |
| Feb 26, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 1,669 | $52.07 | $86.9K | 756-69% |
| Feb 26, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,137 | $52.07 | $59.2K | 1,206-49% |
| Feb 24, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 3,835 | $57.32 | $219.8K | 756-84% |
| Feb 20, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,710 | $56.72 | $97.0K | 1,206-59% |
| Feb 14, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.46 | $388.3K | 11,900-37% | |
| Feb 7, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,092 | $61.99 | $67.7K | 1,206-48% |
| Feb 7, 2025 | ZERBE ROBERT L MD | Sell | 2,500 | $62.50 | $156.3K | 26,595 | |
| Jan 30, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3,908 | $61.99 | $242.3K | 1,206-76% |
| Dec 5, 2024 | Wotton Paul K | Sell | 2,600 | $58.72 | $152.7K | 27,402 | |
| Dec 3, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $58.72 | $587.2K | 58,371 |
VCEL Insiders
Similar Stocks to VCEL
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B